More radiation may decrease breast cancer recurrence risk in some patients
the ONA take:
After conservation surgery, some women who undergo additional radiation given to the lymph nodes along with whole-breast irradiation may be at a reduced risk of breast cancer recurrence, according to a study in the New England Journal of Medicine.
Researchers led by Tim Whelan, MD, of McMaster University’s Michael G. DeGroote School of Medicine looked at women with axillary node-positive or high-risk node-negative breast cancer in order to determine whether adding regional node irradiation to whole-breast irradiation proved more beneficial than whole-breast irradiation alone.
More than 1,800 patients were included in the 14-year study as part of NCIC Clinical Trials Group at Queen’s University in Ontario.
They found that additional radiation to the surrounding lymph nodes reduced risk of subsequence recurrence both locally and at sites distant from the breast.
“This study is important because it shows that additional radiation to the surrounding lymph nodes provides added benefit to women, particularly those with involvement of the lymph nodes in the axilla,” Dr. Whelan said. “Further research is necessary to determine which women are most likely to benefit and who may avoid the additional radiation.”
Some women who undergo additional radiation along with whole-breast irradiation may be at a reduced risk of breast cancer recurrence.
- Acupuncture Improves Postoperative Symptoms in Women Undergoing Surgery for Breast Cancer
- Prehabilitation Program Improves Preoperative Fitness in Patients With Colorectal Cancer
- Combination of Gemcitabine and New CHK1 Inhibitor Is Effective in Soft Tissue Sarcomas
- Alcohol Consumption, Particularly White Wine, Associated With Increased Risk of Melanoma
- In HER2+ Breast Cancer, Higher TIL Levels Associated With Improved OS
- Exercise is as Effective in Treating Metastatic Prostate Cancer as Medication
- Walnut Consumption Changes Gut Microbiome, Decreases Growth of Colon Cancer in Mice
- Vaccine Enters Phase I Study for Safety and Effectiveness in Multiple Myeloma
- Timing Chemotherapy Administration to Circadian Rhythm Improves Drug Effectiveness
- New Therapy Blocks Breast Cancer Cells From Entering and Hiding in Bone Marrow to Form Latent Metastases
- No Difference Between RA Seed Localization and Wire Guided Localization
- BRD4 Inhibitor May Enhance Sensitivity to Endocrine Therapies
- Dual HER2 Blockade With an AI Effective in Advanced Breast Cancer
- Loperamide Regimen May Reduce Diarrhea in Neratinib-treated Patients
- PAM50 HER2-E Subtype Predicts pCR Following Lapatinib, Trastuzumab
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|